Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human PRKCE Stable Cell Line

    [CAT#: S01YF-1023-PY65]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1222-KX445 Magic™ Human PKCε(PRKCE) in Vitro Assay Human Kinase Assay
    S01YF-1222-KX460 Magic™ Human PRKCE in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;NOD;GBC-SD
    Target Classification
    Kinase Cell Lines
    Target Research Area
    CNS Research;Ocular Research
    Related Diseases
    Short Syndrome; Ischemia
    Gene ID
    Human:5581
    UniProt ID
    Human:Q02156

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    PRKCE (Protein Kinase C-epsilon) has been studied in various applications, including cervical cancer, amyotrophic lateral sclerosis (ALS), triple-negative breast cancer (TNBC), and sighthound genetics. In cervical cancer, PRKCE variants have been associated with the disease and its clinicopathological features, suggesting their potential use as prognostic markers and therapeutic targets. In ALS, the impaired expression of PKCε in the motor cortex has been observed, and its activation by Bryostatin-1 has shown long-term survival in degenerating motor neurons. In TNBC, siRNA-7, which targets PRKCE among other cancer-related genes, has exhibited significant efficacy in inhibiting cell viability, making it a potential therapeutic candidate. In sighthounds, multiple origins of the breed have been identified, and PRKCE has been found to be under positive selection, suggesting its role in the morphology of sighthound genomes. Overall, PRKCE has shown promise in various fields, including cancer research and neurodegenerative diseases.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human PRKCE Stable Cell Line (S01YF-1023-PY65). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Skyler Davis (Verified Customer)

    What is the significance of the WWTR1-PRKCE fusion in uterine leiomyoma? Mar 28 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    The WWTR1-PRKCE fusion, resulting from a cryptic translocation, may play a role in the pathogenesis of uterine leiomyoma with 3q- as the sole visible chromosome abnormality. Mar 28 2022

    chat Alex Smith (Verified Customer)

    How do non-coding variants of PRKCE influence its gene transcription and translation? Jan 22 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Non-coding variants of PRKCE can influence the activity of transcription factors, promoting gene transcription and impacting diseases. Jan 22 2022

    Published Data

    Fig.1 The MTS assay was conducted in GBC cells, which had been transfected with the PRKCE construct or PRKCE siRNAs.

    A decrease in PRKCE expression resulted in a lowered IC50 of gemcitabine and an augmented tumor-killing efficacy in NOZ and GBC-SD cells, while conversely, PRKCE overexpression led to a notable increase in the IC50 of gemcitabine, thereby promoting heightened chemoresistance.

    Ref: Wang, Hui, et al. "miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer." Cell death & disease 8.5 (2017): e2770-e2770.

    Pubmed: 28492560

    DOI: 10.1038/cddis.2017.178

    Research Highlights

    Zafar, Sameen. et al. "Exploring the prognostic significance of PKCε variants in cervical cancer." BMC cancer, 2023.
    In this study, pathogenic variations in different domains of Protein Kinase C-epsilon (PKCε) were identified through bioinformatics tools and molecular dynamic simulation. The association of its variants, namely rs1553369874 and rs1345511001, with cervical cancer was determined, along with an assessment of their impact on PKCε's protein-protein interactions. The analysis revealed that these genetic variants were associated with cervical cancer and promoted aberrant interactions with Smad3, potentially activating oncogenic pathways. These findings suggest the prognostic significance of PRKCE gene variants rs1553369874 and rs1345511001. Further validation may enable their use as clinical prognostic markers and therapeutic targets for cervical cancer.
    Zafar, Sameen. et al. "Exploring the prognostic significance of PKCε variants in cervical cancer." BMC cancer, 2023.
    Pubmed: 37667176   DOI: 10.1186/s12885-023-11236-z

    La Cognata, Valentina. et al. "The ε-Isozyme of Protein Kinase C (PKCε) Is Impaired in ALS Motor Cortex and Its Pulse Activation by Bryostatin-1 Produces Long Term Survival in Degenerating SOD1-G93A Motor Neuron-like Cells." International journal of molecular sciences, 2023.
    Amyotrophic lateral sclerosis (ALS) is a rapidly advancing, ultimately fatal neurodegenerative ailment. It results from the gradual loss of upper and lower motor neurons in the brain and spinal cord. Irregularities in multiple PKC-mediated signal transduction pathways in ALS have been identified, involving impaired expression or altered activity of PKC isozymes (α, β, ζ, and δ). This rewriting explores the distribution and cellular localization of the protein kinase C ε-isozyme (PKCε) in human postmortem motor cortex specimens and highlights a substantial decline in both PKCε mRNA (PRKCE) and protein immunoreactivity in some sporadic ALS patients. Additionally, it investigates steady-state levels of pan and phosphorylated PKCε in doxycycline-activated NSC-34 cell lines carrying human wild-type (WT) or mutant G93A SOD1, as well as the prolonged effect of transient Bryostatin-1-induced PKCε activation. Notably, G93A-SOD1 cells exhibited a marked reduction in the phosphoPKCε/panPKCε ratio compared to the WT. Moreover, brief Bryostatin-1-induced PKCε activation conferred long-term survival to degenerating G93A-SOD1 cells under two distinct cell death conditions (serum starvation and chemokine-induced toxicity). Collectively, these findings underscore PKCε's involvement in ALS pathophysiology and propose its pharmacological modulation as a potential neuroprotective strategy, particularly for certain sporadic ALS patients.
    La Cognata, Valentina. et al. "The ε-Isozyme of Protein Kinase C (PKCε) Is Impaired in ALS Motor Cortex and Its Pulse Activation by Bryostatin-1 Produces Long Term Survival in Degenerating SOD1-G93A Motor Neuron-like Cells." International journal of molecular sciences, 2023.
    Pubmed: 37629005   DOI: 10.3390/ijms241612825

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare